.png){kind=icon}
第四阶段研究
Reaching the market is exciting and only the beginning of your compound’s journey. The Phase IV solutions team at Covance helps you realize its full potential.
使你的投资组合和长期投资的价值最大化
Covance has over 30 years of experience world-wide in the late phase industry. We have deep institutional expertise across all therapeutic areas, established investigator relations and broad real world insights. This unique combination can help you define strategies and solutions to efficiently generate and communicate evidence that enables product value demonstration for various stakeholders and to:
及时履行批准后的承诺。
成功地收集真实世界的证据（RWE）并扩大你的化合物的价值。
加强你的市场地位和支持。
填补registration要求和战略后期研究设计。
Engage with patients in meaningful ways and through Patient Reported Outcomes (PROs).
We can maximize the value of your compound through an appropriate design to strategically gather and disseminate real world data
科文斯医疗事务和上市后解决方案团队将与您合作，提供定制的解决方案，以满足您的设计，期间和批准后的需要。
Preparing for and successfully reaching the market is only the beginning of your compound’s journey. Covance combines unique perspectives and precision delivery to help you proactively plan your asset’s path to success from the start.
将数据转化为价值传播是我们工作的核心
- Understanding化合物的生命周期与德不停止signing the clinical development path to generate evidence. It is ultimately about bringing value to the healthcare community and to the patients.
- 转换the scientific and therapeutic advances to improved outcomes and communicating its value to payers and physicians is critical so patients can have fast access to your drug and get timely reimbursed for treatment.
- 连接与世界各地的关键意见领袖和从业者合作，通过我们的调查员关系团队帮助您创造和传播资产价值。
- 认识通过我们的市场准入和商业化团队实现市场差异，我们的团队拥有构建全球价值故事的专业知识，并根据您当地的市场需求进行定制。
在化合物的整个生命周期中实现其价值最大化
无论您是需要探索未来临床计划的设计元素、履行监管承诺、预测业务机会还是对市场事件作出反应，我们都理解您面临的挑战。我们的服务组合为您提供了大量的策略和解决方案，以满足您的需求，包括：
- Natural history studies
- 语用试验
- 疾病/药物登记处
- 生活质量和患者报告结果
- Health outcomes/health economics
- Comparative effectiveness studies
- Real-world data for healthcare decision making
Deliver consistent results through tailored methodologies
Our deep strength in Health Economics Outcomes Research, Patient Reported Outcomes (PROs) instrument development, clinical epidemiology, post-marketing commitments, adherence and risk management and our access to real-world and unique data sources allows us to customize solutions that deliver the results you need. Streamlined Electronic Data Capture platforms provide high-quality cost-effective data.
Develop a strategy built on strong insights and unique access to patient and investigator’s databases
We recognize the challenges you face right up to market access and communicating your product’s value to all involved stakeholders. As your partner, we ensure you have the right strategy to strengthen your market position and maximize your ROI through:
- Our unique access to LabCorp databases via LabCorp patient centers and
- Xcellerate®拥有世界上最大的研究者数据库
Both allow access to 150M de-identified patient lives in the US and 175K investigators and sites worldwide.
我们为真实环境中的证据生成提供集成解决方案，同时积极主动地与我们的客户接触，使执行策略适应他们的期望。